The war in Ukraine has been a test for the pharmaceutical industry, but one that senior leadership have responded to with compassion as well as censure. Many companies are providing financial donations and medical supplies and have pledged to work to address the health needs of everyone affected by the war.
At the same time, more than 400 biopharma leaders signed an open letter condemning the attack, calling for “economic disengagement”...